# Equillium (EQ) — Analyst Forecast

EQ · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/eq/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 10 | 0 | 0 | 10 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | Leerink Partners | Initiated Coverage | Outperform | $6.00 |
| Sep 4, 2026 | Roth Capital | Maintained | Buy | $12.00 |
| Jul 13, 2026 | Piper Sandler | Initiated Coverage | Overweight | $20.00 |
| Jun 2, 2026 | Roth Capital | Maintained | Buy | $12.00 |
| May 28, 2026 | Roth Capital | Maintained | Buy | $12.00 |
| May 28, 2026 | Leerink Partners | Upgraded | Market Perform → Outperform | $6.00 |
| Apr 17, 2026 | Roth Capital | Maintained | Buy | $12.00 |
| Apr 16, 2026 | B. Riley Securities | Initiated Coverage | Buy | $6.00 |
| Apr 14, 2026 | Raymond James | Initiated Coverage | Strong Buy | $6.00 |
| Mar 13, 2026 | Roth Capital | Initiated Coverage | Buy | $12.00 |
| Mar 28, 2025 | Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 |
| Nov 1, 2024 | Jones Trading | Downgraded | Buy → Hold | — |
| Aug 19, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Jun 5, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| May 17, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Apr 2, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Dec 26, 2023 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Nov 13, 2023 | HC Wainwright & Co. | Maintained | Buy | $4.50 |
| Aug 14, 2023 | Cantor Fitzgerald | Maintained | Overweight | $2.80 |
| Aug 14, 2023 | HC Wainwright & Co. | Maintained | Buy | $5.50 |

## Frequently Asked Questions

### Is EQ a buy, sell, or hold?

Analysts covering Equillium currently average a Buy rating: 10 buy, 0 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on EQ?

On Oct 12, 2026, Leerink Partners initiated coverage of Equillium at Outperform with a price target of $6.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).